Clinical & Performance Evaluation

MDR Article 61 & IVDR Article 56 — Evidence-Based Safety & Performance

Every medical device and IVD must undergo a clinical evaluation (MDR) or performance evaluation (IVDR) to demonstrate that it is safe and achieves its intended performance. This is not a one-time exercise — it is aliving process that must be continuously updated throughout the device's lifecycle with post-market data.

MDR Clinical Evaluation vs IVDR Performance Evaluation

MDR — Clinical Evaluation

• Article 61 & Annex XIV
• Assesses safety & clinical performance
• Based on clinical data (literature, experience, investigations)
• Documented in Clinical Evaluation Report (CER)
• Ongoing via PMCF (Post-Market Clinical Follow-up)
• Higher-risk devices may need clinical investigations

IVDR — Performance Evaluation

• Article 56 & Annex XIII
• Assesses scientific validity, analytical & clinical performance
• Based on performance data (studies, literature, experience)
• Documented in Performance Evaluation Report (PER)
• Ongoing via PMPF (Post-Market Performance Follow-up)
• Higher-risk IVDs may need performance studies

Clinical Evaluation Process (MDR)

Clinical evaluation under the MDR (Article 61, Annex XIV Part A) is a systematic and planned process to continuously generate, collect, analyse, and assess clinical data pertaining to a device. Its purpose is to verify the safety and performance — including clinical benefits — of the device when used as intended by the manufacturer.

Why This Matters for You

The Clinical Evaluation Report (CER) is a key document you can request from suppliers. It demonstrates the evidence base behind a device's safety and performance claims. Understanding this process helps you evaluate whether devices used in your hospital are supported by adequate clinical evidence.

Key Regulatory References

MDR Article 61

Clinical Evaluation

Core requirement for clinical evaluation of medical devices

MDR Annex XIV

Clinical Evaluation & PMCF

Part A: Clinical Evaluation procedure; Part B: PMCF requirements

MDR Articles 62–82

Clinical Investigations

Requirements for conducting prospective clinical studies

IVDR Article 56

Performance Evaluation

Core requirement for performance evaluation of IVDs

IVDR Annex XIII

Performance Evaluation & PMPF

Part A: Performance evaluation procedure; Part B: PMPF requirements

IVDR Articles 57–77

Performance Studies

Requirements for conducting IVD performance studies

MDCG 2020-5

Clinical Evaluation — Equivalence

Guidance on demonstrating equivalence under MDR

MDCG 2020-6

Clinical Evidence for Legacy Devices

Sufficient clinical evidence for legacy devices transitioning to MDR

MDCG 2020-13

Clinical Investigation Application

Guidance on clinical investigation application/notification

MEDDEV 2.7/1 Rev 4

Clinical Evaluation Guide

Widely referenced guidance on clinical evaluation methodology (MDD-era but still informative)

Key Takeaways

Request the Clinical Evaluation Report (CER) or Performance Evaluation Report (PER) from device suppliers during procurement

Understand that clinical evidence is the foundation for device safety — not just regulatory paperwork

Know your institution's role if participating in clinical investigations — ethics, informed consent, and safety reporting

Your post-market feedback (complaints, incidents) is vital data that feeds back into the manufacturer's clinical evaluation

Irish Context — Clinical Evidence & the HPRA

The HPRA may request clinical evaluation reports from manufacturers as part of market surveillance. Hospital clinical teams may be asked to contribute post-market clinical follow-up (PMCF) data.

Clinicians in HSE facilities participating in PMCF studies should ensure these are conducted in line with the hospital research ethics framework.

This is educational content only and is not an accredited or externally verified course. Always refer to official HPRA publications and your facility's own policies.